Refractory spasm of coronary arteries and grafted conduits after isolated coronary artery bypass surgery

Roberto Lorusso1, Elena Crudeli, Fabiana Lucà

  • 1Cardiac Surgery Unit, Community Hospital, Brescia, Italy. robertolorusso@iol.it

Insights

Refractory vascular spasm after coronary artery bypass grafting is rare and often fatal. Prompt extracorporeal membrane oxygenation and circulatory support can successfully manage this critical condition.

Area of Science:

  • Cardiovascular Surgery
  • Intensive Care Medicine
  • Vascular Physiology

Background:

  • Refractory vascular spasm (RVS) affecting the entire coronary system and grafts post-coronary artery bypass grafting (CABG) is a rare but severe complication.
  • Current management strategies for diffuse RVS lack consensus.

Purpose of the Study:

  • To investigate the clinical presentation, management, and outcomes of patients experiencing diffuse RVS after CABG.
  • To evaluate the efficacy of extracorporeal membrane oxygenation (ECMO) in managing this condition.

Main Methods:

  • A retrospective review of 5,762 isolated CABG patients between 1986 and 2009 identified 7 cases of diffuse RVS.
  • Clinical data, including surgical details, perioperative events, and outcomes, were analyzed.
  • Comparison was made with 18 patients experiencing single-vessel or conduit vasospasm.

Main Results:

  • Diffuse RVS occurred 3-8 hours post-CABG, presenting with ischemic ECG changes and cardiogenic shock in most patients.
  • Initial aggressive pharmacologic treatment and counterpulsation failed in 5 of the first 7 patients, leading to death.
  • The last 2 patients treated with rapid ECMO institution survived, with complete resolution of vasospasm.

Conclusions:

  • Diffuse RVS post-CABG is a rare, highly lethal event.
  • Prompt institution of extracorporeal membrane oxygenation and controlled cardiocirculatory assistance is crucial for survival.
  • Aggressive intervention with ECMO offers a viable solution for managing this dramatic complication.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...